Skip to content

Clinical efficacy of tendon clearing technique combined with Zizhu ointment in the treatment of non-ischemic diabetic foot ulcers

Clinical efficacy of tendon clearing technique combined with Zizhu ointment in the treatment of non-ischemic diabetic foot ulcers

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000230
Enrollment
Unknown
Registered
2025-02-08
Start date
2024-10-09
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot ulcers

Interventions

Intervention :Intervention groups:Tendon Cleansing + Zi Zhu Ointment for External Application
Control:Control groups:Cleansing treatment + nano-silver medical antimicrobial dressing for external use

Sponsors

Shuguang Hospital Affiliated Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Comply with the quality control standard of single disease of diabetic foot gangrene and the diagnostic standard of non-ischemic diabetic foot in Modern Diabetes Diagnosis and Treatment approved by Shanghai Municipal Science and Technology Commission; and comply with the diagnostic standard of Chinese medicine evidence and symptoms. (2) The age is 40 to 80 years old; (3) Patients' ankle-brachial index is within the required range: 0.8 < ankle-brachial index < 1.3; (4) All patients signed an informed consent for treatment.

Exclusion criteria

Exclusion criteria: (1) Age 80 years; (2) Those with ischemic diabetic foot ulcers; (3) Those with severe hepatic or renal insufficiency defined as alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) =2* upper limit of normal (ULN) as defined by the Center or blood creatinine (Scr) >1.5*UNL; (4) Patients with malignant tumors or psychiatric disorders; (5) Those treated with surgical or interventional angioplasty; (6) Those who had participated in other clinical trials 4 weeks prior to enrollment.

Design outcomes

Primary

MeasureTime frame
Ulcer healing rate;

Secondary

MeasureTime frame
Chinese Medicine Symptom Score;VAS score;Serum inflammatory factors NLRP3 IL-1ß IL-18;

Countries

CHINA

Contacts

Public ContactLIUGuoBin

Shuguang Hospital Affiliated Shanghai University of Traditional Chinese Medicine

drlguobin@163.com15800885533

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026